Introduction {#S1}
============

Bone is a multi-functional organ that not only sustains the vertebrate skeletons but also provides mineral storage and space for hematopoiesis throughout life. This tissue is remodeled continuously to maintain its structure and adapt to the changing environment. Bone remodeling is driven by a balance of cells that degrade and produce bone^[@R1]^. Osteoblasts and osteocytes play an essential role in the production of mineralized bone and are derived from mesenchymal precursors or skeletal stem cells^[@R2]--[@R4]^. Osteoclasts are involved in the resorption of bone tissue and are a monocyte/macrophage lineage cell^[@R5],\ [@R6]^ that differentiate from precursors under the influence of receptor activator of NF-κβ ligand (RANKL)^[@R7],\ [@R8]^ and undergo cell fusion to form a multinucleated cell^[@R9],\ [@R10]^.

Monocyte/macrophage lineage cells can differentiate from several precursors, and the different precursors give rise to distinct tissue-specific macrophage populations. Hematopoietic stem cells (HSCs), the yolk-sac, or cells in the fetal liver can all produce macrophages^[@R11],\ [@R12]^. In mice, primitive hematopoiesis starts around embryonic day 7 (E7) in the blood island of the yolk-sac^[@R13]--[@R17]^. Early erythromyeloid progenitors (EMPs) appear around E7--7.5 in the yolk-sac^[@R11],\ [@R18]^ and can differentiate into colony stimulating factor 1 receptor (CSF1R) positive yolk-sac macrophages at E8.5^[@R14],\ [@R19]^. This first wave of EMPs occur in a transcriptional activator Myb-independent manner^[@R17],\ [@R20]^. Myb-independent early EMPs can develop from E8.25 and differentiate into CX3C chemokine receptor 1 (CX3CR1) positive yolk-sac macrophages at E8.5, which are also called premacrophages, resulting in a source of tissue-resident macrophages^[@R21]^. The second wave of EMPs, also known as late EMPs, emerge from the yolk-sac at E8.5 and migrate to the fetal liver, resulting in a source of fetal liver monocytes^[@R22]^. Later in development, hematopoietic stem cell precursors (pro-HSCs) emerge in the aortogonado-mesonephros region at E10.5 and differentiate to embryonic HSCs at E12.5, which later shift to the bone marrow^[@R17]^. Bone marrow HSCs eventually establish the circulating monocyte-derived macrophages^[@R11]^.

Here we sought to identify osteoclasts derived from EMPs and investigate their contribution to postnatal bone homeostasis and remodeling. Our fate-mapping experiments and single cell RNA-sequencing (scRNA-seq) reveal that yolk-sac macrophages of EMP origin differentiate into osteoclasts in the neonatal stage and these cells contribute to building the medullary space for interosseous hematopoiesis. In addition, progenies of Cx3cr1^+^ yolk-sac macrophages provide long-lasting osteoclast precursors that participate in cell-cell fusion with local precursors and contribute to the postnatal bone remodeling in both physiological and pathological setting. Parabiosis and splenectomy show that Cx3cr1^+^ yolk-sac macrophage decedents residing in adult spleen migrate to the injury site via the bloodstream and differentiate into osteoclasts contributing to the remodeling after bone injury.

RESULTS {#S2}
=======

Csf1r^+^ yolk-sac macrophage give rise to the neonatal osteoclasts {#S3}
------------------------------------------------------------------

To investigate the potential contribution of EMPs to the postnatal osteoclast, *Csf1r-Mer-iCre-Mer; Rosa26*^*tdTomato*^ (*R26*^*tdTomato*^) mice were singly injected with 4-hydroxytamoxifen (4OHT) at E7.5, E8.5 or, E9.5, resulting in irreversible tdTomato expression in *Csf1r-*expressing cell and their progenies ([Fig. 1a](#F1){ref-type="fig"}). Since *Csf1r*-expressing macrophages in the yolk-sac appear at E8.5^[@R18],\ [@R22]^ and peek between E9.5 and E10.5^[@R23]^, induction at E8.5 will label the majority of Csf1r^+^ yolk-sac macrophages and their progenies^[@R24]^. E9.5 induction labels macrophages derived from definitive myeloid progenitors that emerge later than yolk-sac macrophages. Because Cre-recombination peaks at 6 hrs and terminates 24 hrs after 4OHT injection^[@R24],\ [@R25]^, induction at E7.5 should barely label the earliest cells expressing *Csf1r* with tdTomato.

At postnatal day (P) 0 we detected a few tdTomato expressing cells in the femur of the mice labeled at E7.5 ([Fig. 1b](#F1){ref-type="fig"}, [c](#F1){ref-type="fig"}) and none were identified in 4OHT untreated mice ([Extended Data Fig. 1a](#F7){ref-type="fig"}). In contrast, induction at E8.5 and E9.5 yielded tdTomato and V-type proton pump-3 (Vpp3)^[@R26]^ expressing multinucleated osteoclasts in P0 and 0.5-month-old femur ([Fig. 1e](#F1){ref-type="fig"}, [f](#F1){ref-type="fig"}). In mice labeled at E8.5, there were a few tdTomato^+^ cells in the diaphysis and none were identified in the metaphysis by two weeks of age ([Fig. 1b](#F1){ref-type="fig"}, [c](#F1){ref-type="fig"}, [d](#F1){ref-type="fig"}). On the other hand, the number of tdTomato^+^ cells in the metaphysis and diaphysis of the mice labeled at E9.5 were diminished at two months of age and disappeared by 6 months of age ([Fig. 1b](#F1){ref-type="fig"}, [c](#F1){ref-type="fig"}). To verify that tdTomato^+^ multinucleated cells were osteoclasts, we counterstained the cells with tartrate-resistant acid phosphatase (TRAP) ([Fig. 1g](#F1){ref-type="fig"}). More than 80% of TRAP^+^ cells expressed tdTomato in the femur of the mice labeled at E8.5, verifying Csf1r^+^ yolk-sac macrophage contributed to osteoclasts in the P0 femur ([Fig. 1h](#F1){ref-type="fig"}). However, the percentage of tdTomato^+^TRAP^+^ osteoclasts labeled at E8.5 decreased with age and disappeared within two weeks of age in the metaphysis. Further, tdTomato^+^TRAP^+^ cells labeled at E9.5 also decreased over time and almost disappeared within six months of age ([Fig. 1h](#F1){ref-type="fig"}). In addition to the osteoclast-specific marker expression of Vpp3 and TRAP, the multinuclear nature of these cells is consistent with the notion that tdTomato^+^TRAP^+^ cells are not circulating macrophages or monocytes.

Cx3cr1^+^ yolk-sac macrophages give rise to the osteoclasts that survive in adulthood {#S4}
-------------------------------------------------------------------------------------

EMPs give rise to fractalkine receptor CX3CR1 expressing yolk-sac macrophages, also known as premacrophages^[@R21]^ at E8.5 and will then colonize the whole embryo starting at E9.5^[@R27]^. We next generated *Cx3cr1*^*CreER*^*; R26*^*tdTomato*^ mice in which 4OHT could pulse label *Cx3cr1*-expressing cells and their progenies^[@R28]--[@R31]^ ([Fig. 2a](#F2){ref-type="fig"}). There was a limited contribution of tdTomato^+^ cells in the P0 femur labeled at E8.5 ([Fig. 2b](#F2){ref-type="fig"}, [c](#F2){ref-type="fig"}) and no tdTomato expression in 4OHT untreated mice ([Extended Data Fig. 2a](#F8){ref-type="fig"}). However, induction at E9.5 produced abundant tdTomato^+^ multinucleated cells in both the metaphysis and diaphysis of P0 femur ([Fig. 2b](#F2){ref-type="fig"}, [c](#F2){ref-type="fig"}, [e](#F2){ref-type="fig"}). By two weeks of age, the number of tdTomato^+^ cells was too sparse to detect in the metaphysis of mice induced at E8.5 or 9.5, but tdTomato^+^ cells were detected in the diaphysis with induction at E9.5 ([Fig. 2b](#F2){ref-type="fig"}, [c](#F2){ref-type="fig"}, [d](#F2){ref-type="fig"}). Notably, more than 30% of TRAP^+^ osteoclasts expressed tdTomato in the femur at 2 months of age when mice were labeled with 4OHT at E8.5 or E9.5 ([Fig. 2f](#F2){ref-type="fig"}, [g](#F2){ref-type="fig"}). At 6 months of age, tdTomato^+^TRAP^+^ osteoclasts labeled at E9.5 survived and contributed to the remodeling of the adult femur. tdTomato^+^ cells were also detected in other skeletal elements such as neonatal calvaria, adult scapula and vertebral body, and they lacked expression of macrophage marker F4/80 ([Extended Data Fig. 2b](#F8){ref-type="fig"}, [c](#F8){ref-type="fig"}, [d](#F8){ref-type="fig"}). Thus, Cx3cr1^+^ yolk-sac macrophages of EMP origin give rise not only to the neonatal osteoclasts but also provide long-lasting osteoclasts in adult bones.

EMPs and HSCs give rise to the postnatal osteoclasts {#S5}
----------------------------------------------------

To examine the contribution of HSCs to the postnatal osteoclast, we generated *Flt3-Cre; R26*^*tdTomato*^ mice and analyzed their femur at E17.5, P0 and, 2 months of age. They exhibited tdTomato^+^ cells in the femur at all time points ([Fig. 3a](#F3){ref-type="fig"}). We confirmed negative tdTomato expression in E17.5 femur of Cre-negative littermate controls ([Extended Data Fig. 3a](#F9){ref-type="fig"}) and negligible mRNA expression of *Cre* in E8.5 embryos compared to bone marrow cells from 2-month-old *Flt3-Cre; R26*^*tdTomato*^ mice, indicating non-leakiness of *Flt3-Cre* mice ([Extended Data Fig. 3b](#F9){ref-type="fig"}). In addition to the expression of TRAP and Vpp3, the multinuclear nature of these cells is consistent with tdTomato^+^TRAP^+^ cells being osteoclasts ([Fig. 3b](#F3){ref-type="fig"}, [c](#F3){ref-type="fig"}). The percentage of tdTomato^+^TRAP^+^ osteoclasts to total TRAP^+^ osteoclasts slightly increased during early bone development and reached to 94.6% in P0 and 87.2% in 2-month-old femur of *Flt3-Cre; R26*^*tdTomato*^ mice ([Fig. 3d](#F3){ref-type="fig"}). Since *Flt3* is not expressed in yolk-sac macrophages of EMP origin^[@R19],\ [@R20],\ [@R32]^, but are expressed specifically in the HSC lineage, overlapping percentage of tdTomato^+^TRAP^+^ osteoclast in both fate-mapping experiments suggest cell-cell fusion between HSCs- and EMPs-derived precursors give rise to giant multinucleated osteoclasts.

Next, we examined osteoclast precursors in the postnatal bone marrow. Negligible tdTomato^+^ cells were identified by fluorescence-activated cell sorting (FACS) in the bone marrow cells (BMCs) from *Csf1r-Mer-iCre-Mer; R26*^*tdTomato*^ and *Cx3cr1*^*CreER*^*; R26*^*tdTomato*^ mice induced at E8.5 or 9.5, respectively ([Fig. 3e](#F3){ref-type="fig"}, [f](#F3){ref-type="fig"}, [Extended Data 3c](#F9){ref-type="fig"}). In contrast, 89.6 % of CD45^+^ BMCs from *Flt3-Cre; R26*^*tdTomato*^ mice expressed tdTomato and 49.6% of them were CD11b^high^F4/80^int^ monocyte rather than F4/80^high^CD11b^int^ macrophages ([Fig. 3e](#F3){ref-type="fig"}, [f](#F3){ref-type="fig"}). Further, 2.32% of CD45^+^tdTomato^+^ BMCs from *Flt3-Cre; R26*^*tdTomato*^ mice expressed Receptor activator of NF-κβ (Rank; encoded by the *Tnfrsf11a* gene), representing a possible source of HSC-derived osteoclast precursors.

We next investigated the differentiation capacity of EMP- and HSC-derived precursors to osteoclasts *in vitro*. First, we isolated tdTomato^+^ cells from single cell suspension of whole E14.5 embryos of *Csf1r-Mer-iCre-Mer; R26*^*tdTomato*^ mice labeled at E8.5 and *Cx3cr1*^*CreER*^*; R26*^*tdTomato*^ mice labeled at E9.5. CD45^+^ cells from E14.5 *Csf1r-Mer-iCre-Mer; R26*^*tdTomato*^ mice expressed tdTomato at 14.2%, and 60.5% of these cells were F4/80^high^CD11b^int^ macrophages and 40.9% expressed RANK ([Extended Data Fig. 3d](#F9){ref-type="fig"}, [e](#F9){ref-type="fig"}, [f](#F9){ref-type="fig"}). CD45^+^ cell from *Cx3cr1*^*CreER*^*; R26*^*tdTomato*^ mice labeled at E9.5 expressed tdTomato at 3.19% and a higher population of the cells were F4/80^high^CD11b^int^ macrophage (91.8%) and RANK^+^ cells (69.2%). We next cultured tdTomato^+^ cells from E14.5 embryos of *Csf1r-Mer-iCre-Mer; R26*^*tdTomato*^ mice (4OHT at E8.5) and *Cx3cr1*^*CreER*^*; R26*^*tdTomato*^ mice (4OHT at E9.5) and differentiated them into osteoclasts under macrophage colony-stimulating factor (M-CSF) and soluble RANKL stimulation^[@R33]^. We also cultured BMCs from 2-month-old *Flt3-Cre; R26*^*tdTomato*^ and *C57BL/6J* mice and differentiated them into osteoclasts. All of these types of cells were equally capable of differentiating into tdTomato^+^TRAP^+^ multinucleated osteoclasts *in vitro* ([Fig. 3g](#F3){ref-type="fig"}, [h](#F3){ref-type="fig"}).

EMP-derived osteoclast precursors arise independently from HSC lineage {#S6}
----------------------------------------------------------------------

To evaluate the possible contribution of yolk-sac macrophage of EMP origin to the postnatal osteoclast pool, we performed single cell RNA-sequencing (scRNA-seq) on developing embryos. Single cell suspensions of whole embryos at E14.5 from *Csf1r-Mer-iCre-Mer; Csf1r-EGFP; R26*^*tdTomato*^ mice labeled at E8.5 and *Cx3cr1*^*CreER*^*; R26*^*tdTomato*^ mice labeled at E9.5 were investigated. Three cell populations, tdTomato^+^EGFP^−^, tdTomato^+^EGFP^+^, and tdTomato^−^EGFP^+^ were isolated from the whole embryo of *Csf1r-Mer-iCre-Mer; Csf1r-EGFP; R26*^*tdTomato*^ mice. tdTomato^+^Cx3cr1^−^, tdTomato^+^Cx3cr1^+^, and tdTomato^−^Cx3cr1^+^ cells were isolated from *Cx3cr1*^*CreER*^*; R26*^*tdTomato*^ mice ([Extended Data Fig. 4a](#F10){ref-type="fig"}, [b](#F10){ref-type="fig"}). We profiled over 35,000 single cells pooled from 4 embryos using two biological replicates for each genotype. Unsupervised clustering assigned the cells into distinct 29 and 21 subpopulations from *Csf1r-Mer-iCre-Mer; Csf1r-EGFP; R26*^*tdTomato*^ and *Cx3cr1*^*CreER*^*; R26*^*tdTomato*^ mice respectively ([Fig. 4a](#F4){ref-type="fig"}, [f](#F4){ref-type="fig"}), and the cell subpopulations were readily identified with known marker genes ([Fig. 4b](#F4){ref-type="fig"}, [c](#F4){ref-type="fig"}, [d](#F4){ref-type="fig"}, [g](#F4){ref-type="fig"}, [h](#F4){ref-type="fig"}, [i](#F4){ref-type="fig"}, [Extended Data Fig. 4c](#F10){ref-type="fig"}, [d](#F10){ref-type="fig"})

tdTomato^high^Csf1r^high^ cells from *Csf1r-Mer-iCre-Mer; Csf1r-EGFP; R26*^*tdTomato*^ mice, which are indicative of progenies of Csf1r^+^ yolk-sac macrophages, were mainly present in clusters 2, 4, 8, 10, 14, 18, 22, 23, and 29 ([Fig. 4a](#F4){ref-type="fig"}, [b](#F4){ref-type="fig"}). These cells expressed pan-macrophage markers, such as *Adgre1* and *Aif1* ([Fig. 4c](#F4){ref-type="fig"}). tdTomato^low^Csf1r^high^ cells which are indicative of HSC-derived monocyte/macrophage were present in clusters 1, 3, 6, 7, and 24 ([Fig. 4a](#F4){ref-type="fig"}, [b](#F4){ref-type="fig"}). Genes, such as *Ccr2* and *Ly6c2*, encoding monocyte makers, were expressed in these clusters ([Fig. 4c](#F4){ref-type="fig"}). Cluster 10 was enriched with genes that were known as markers of Kupper cell and splenic red pulp macrophage, such as *Spic* and *Id3*^[@R21]^. Although 4OHT induction at E8.5 labeled mainly yolk-sac macrophages, it also labeled other subpopulations of cells such as Ngp^+^Ly6g^+^ neutrophils (Cluster 15), Alas2^+^HbA2^+^ erythrocytes (Cluster 27), and Pecam1^+^Cdh5^+^ endothelial cells (Cluster 20) ([Fig. 4c](#F4){ref-type="fig"}, [Extended Data Fig. 4c](#F10){ref-type="fig"}). Importantly, cluster 23 was a Dcstamp^+^Ocstamp^+^Atp6v0d2^+^Ctsk^+^Mmp9^+^ osteoclast-specific population^[@R34]--[@R38]^. In cells from *Cx3cr1*^*CreER*^*; R26*^*tdTomato*^ mice, tdTomato^high^Cx3cr1^high^ cells were located in clusters 2, 4, 6, and 7, which represented yolk-sac-derived macrophage populations ([Fig. 4f](#F4){ref-type="fig"}, [g](#F4){ref-type="fig"}). They demonstrated higher expression levels of *Mrc1*, *Lyve1*, *C1q1*, *Trem2,* and *Hexb*. On the other hand, cluster 1 and 3 included Cx3cr1^high^tdTomato^low^ cells which expressed high levels of *Ccr2* and *Ifitm3* representing HSC-derived monocyte/macrophage ([Fig. 4i](#F4){ref-type="fig"}).

To delineate the distribution of tdTomato^+^ fate-mapping cells to HSC lineage, we quantified the number of tdTomato^+^ cells in the Flt3^+^ clusters. Total 726 tdTomato^+^ cells (7.02%) from *Csf1r-Mer-iCre-Mer; Csf1r-EGFP; R26*^*tdTomato*^ mice distributed to cluster 11, 12, 19, and 21 ([Fig. 4e](#F4){ref-type="fig"}) and total 73 tdTomato^+^ cells (1.08%) from *Cx3cr1*^*CreER*^*; R26*^*tdTomato*^ mice distributed to cluster 16 ([Fig. 4j](#F4){ref-type="fig"}). Though tdTomato^+^ cells from both mice contributed to Flt3^+^ HSC lineage, the expression levels of Flt3 in tdTomato^+^ cells were negligible ([Extended Data Fig. 4e](#F10){ref-type="fig"}). This data supports the notion that fate mapped EMP-derived tdTomato^+^ cells arose independently from Flt3^+^ HSC lineage.

To characterize the EMP-derived osteoclast precursors, we next isolated tdTomato^+^Tnfrsf11a^+^Ptprc^+^ cells from the data of *Csf1r-Mer-iCre-Mer; Csf1r-EGFP; R26*^*tdTomato*^ and *Cx3cr1*^*CreER*^*; R26*^*tdTomato*^ mice, and combined them to visualize their expression profiles. Unsupervised clustering showed 13 distinct populations ([Extended Data Fig. 5a](#F11){ref-type="fig"}, [b](#F11){ref-type="fig"}). Cluster 9 was an osteoclast-specific cluster, containing cells highly expressing *CtsK*, *Mmp9*, *Ocstamp*, and *Nfatc1* as well as *tdTomato*, *Tnfrsf11a,* and *Csf1r* representing EMP-derived mature osteoclast populations ([Extended Data Fig. 5a](#F11){ref-type="fig"}, [c](#F11){ref-type="fig"}, [Supplementary Table 1](#SD2){ref-type="supplementary-material"}). In addition, cells in cluster 6 expressed several genes related to osteoclast maturation and differentiation, such as activator protein-1 (AP-1) transcriptional factors (*Junb/d* and *Fos*)^[@R39],\ [@R40]^, C1q complement complex (*C1qa/b/c*)^[@R41]^, TNF signaling pathway genes (*Tnf* and *Tnfsf9*)^[@R42]^, Interleukin (IL)-1 mediated signaling pathway genes (*Il-1α* and *β*)^[@R43]^, and Fc gamma receptors (*Fcgr3*, and *Fcgrt*)^[@R44],\ [@R45]^ ([Supplementary Table 2](#SD2){ref-type="supplementary-material"}). Pathway analysis of significantly expressed genes in cluster 6 also included several promotive osteoclast differentiation pathways as well as suppressive cytokine pathways such as IL-4, 12, 13, and 10 signaling^[@R46],\ [@R47]^ ([Extended Data Fig. 5d](#F11){ref-type="fig"}). Thus, cells belonging cluster 6 were likely the source of EMP-derived osteoclast precursors.

Cx3cr1^+^ yolk-sac macrophage descendants provide osteoclasts after bone injury {#S7}
-------------------------------------------------------------------------------

To examine the contribution of EMP-derived osteoclast precursors to adult bone remodeling after injury, 2-month-old *Cx3cr1*^*CreER*^*; R26*^*tdTomato*^ mice induced with 4OHT at E9.5 were injured by generating a drill hole in the femur^[@R48]^ and were analyzed 3, 7, 14 and 21 days after injury ([Fig. 5a](#F5){ref-type="fig"}). Three days after injury, F4/80^+^ macrophage and inflammatory cells infiltrated into the injury site ([Extended Data Fig. 6a](#F12){ref-type="fig"}, [b](#F12){ref-type="fig"}). Serial μCT and histological images revealed that the injury site filled with new bone within 2 weeks, which was remodeled at 21 days ([Fig. 5b](#F5){ref-type="fig"} and [Extended Data Fig. 6a](#F12){ref-type="fig"}). The number of TRAP^+^ osteoclasts increased at day 7, and their numbers peaked on day 14 ([Fig. 5c](#F5){ref-type="fig"}, [d](#F5){ref-type="fig"}). tdTomato^+^TRAP^+^ cells began to increase after day 7, with larger numbers at day 14 ([Fig. 5e](#F5){ref-type="fig"}, [f](#F5){ref-type="fig"}, [h](#F5){ref-type="fig"}). About 35% of TRAP^+^ cells coexpressed tdTomato^+　^at day 14, indicating EMP-derived osteoclasts contributing to the bone remodeling after injury ([Fig. 5g](#F5){ref-type="fig"}). The tdTomato^+^TRAP^+^ cells were multinucleated giant cells ([Fig. 6i](#F6){ref-type="fig"}) but lacked expression of F4/80 ([Fig. 5j](#F5){ref-type="fig"}), indicating that these cells were not macrophage/monocyte but osteoclasts.

We also analyzed 2-month-old *Csf1r-Mer-iCre-Mer; R26*^*tdTomato*^ mice labeled at E9.5. We could detect a few tdTomato^+^ cells in the bone marrow ([Extended Data Fig. 6c](#F12){ref-type="fig"}). However, the contribution of tdTomato^+^ cell to TRAP^+^ osteoclasts was negligible ([Extended Data Fig. 6d](#F12){ref-type="fig"}, [e](#F12){ref-type="fig"}).

Next, *Flt3-Cre; R26*^*tdTomato*^ mice were analyzed 7 and 14 days after the drill hole injury ([Fig. 5k](#F5){ref-type="fig"}). Fate mapping data showed that tdTomato^+^ multinucleated cells coexpressed TRAP and Vpp3, representing osteoclasts of HSC origin ([Fig. 5l](#F5){ref-type="fig"}). HSC-derived osteoclasts had already migrated to the injury site at day 7 and provided tdTomato^+^TRAP^+^ osteoclasts around the injury site ([Fig. 5m](#F5){ref-type="fig"}). The overlapping distribution of EMP-derived ([Fig. 5g](#F5){ref-type="fig"}, 35.1%) and HSC-derived ([Fig. 5n](#F5){ref-type="fig"}, 90.0%) tdTomato^+^TRAP^+^ osteoclast at day 14 provide a possibility of cell-cell fusion between both lineage cells.

Cx3cr1^+^ yolk-sac macrophage descendants can migrate to bone injury sites through blood circulation from a reservoir in the spleen {#S8}
-----------------------------------------------------------------------------------------------------------------------------------

Cells from EMP-derived osteoclast precursors could migrate from proliferating cells adjacent to the bone injury or through a peripheral source in the circulation. Immunostaining for Ki67 showed low proliferation potential of tdTomato^+^ cells ([Extended Data Fig. 7a](#F13){ref-type="fig"}, [b](#F13){ref-type="fig"}), raising the possibility that these cells migrated through the circulation to the injury site from a distal source. To determine the source from which these cells arose, a parabiotic union^[@R49]^ was achieved between *Cx3cr1*^*EGFP/+*^ and *Cx3cr1*^*CreER*^*; R26*^*tdTomato*^ mice labeled at E9.5. Three weeks after parabiosis, a bone injury was generated in *Cx3cr1*^*EGFP/+*^ mice and the injury site was analyzed 2 weeks after surgery ([Fig. 6a](#F6){ref-type="fig"}). EGFP^+^ cells migrated into the *Cx3cr1*^*CreER*^*; R26*^*tdTomato*^ mice were showing effective blood sharing between two mice ([Fig. 6b](#F6){ref-type="fig"}, [c](#F6){ref-type="fig"}). A population of tdTomato^+^ cells was observed at the bone injury site in *Cx3cr1*^*EGFP/+*^ mice and some of tdTomato^+^ cells coexpressed TRAP ([Fig. 6d](#F6){ref-type="fig"}). We also found tdTomato- and EGFP-double-positive multinucleated cells at the injury site ([Fig. 6e](#F6){ref-type="fig"}). This data supports our hypothesis that migrating EMP-derived tdTomato^+^ cells can fuse with local EGFP^+^ cells and give rise to one multinucleated osteoclast contributing bone remodeling after injury. The number of tdTomato^+^ cells in the contralateral femur was significantly lower than that of the injured femur ([Extended Data Fig. 7c](#F13){ref-type="fig"}, [d](#F13){ref-type="fig"}, [e](#F13){ref-type="fig"}). Thus, Cx3cr1^+^ yolk-sac macrophage descendants were able to migrate through the bloodstream and differentiated into osteoclasts with possible fusion with local cells.

The spleen serves as a reservoir of osteoclast precursors in adult animals^[@R50]^. Therefore, we investigated if the spleen could be a space of EMP-derived cells that could provide osteoclasts at the site of a bone injury. We performed a splenectomy and damaged the bone using drill hole surgery in *Cx3cr1*^*CreER*^*; R26*^*tdTomato*^ mice labeled at E9.5 ([Fig. 6f](#F6){ref-type="fig"}). tdTomato^+^ cells in the spleen of *Cx3cr1*^*CreER*^*; R26*^*tdTomato*^ mice mainly distributed in the red pulp ([Fig. 6g](#F6){ref-type="fig"}, [h](#F6){ref-type="fig"}), consistent with a previous report showing that macrophages in the red pulp partially originate from primitive yolk-sac^[@R51],\ [@R52]^. We found that the number of tdTomato^+^ cells and tdTomato^+^TRAP^+^ osteoclasts were substantially decreased in mice that underwent a splenectomy ([Fig. 6i](#F6){ref-type="fig"}, [j](#F6){ref-type="fig"}). These data provide a possibility that the spleen can be a pool of EMP-derived osteoclast precursors.

Discussion {#S9}
==========

Here we investigated the origin of postnatal osteoclasts. We found that the majority of osteoclasts in neonatal bones are derived from yolk-sac macrophage of EMP origin. These cells likely participate in cell-cell fusion with HSC lineage precursors. We also found that Cx3cr1^+^ yolk-sac macrophage descendants uniquely give rise to long-lasting osteoclast precursors and provide osteoclasts in adult bone. Those EMP-derived precursors can migrate to the injury site via the bloodstream and can fuse with local precursors to create multinucleated giant osteoclasts contributing to bone remodeling after injury ([Extended Data Fig. 8](#F14){ref-type="fig"}).

Jacome-Galarza et al. showed that osteoclasts of EMP origin are required for normal bone development and tooth eruption^[@R32]^. However, the contribution of these embryonic osteoclast precursors to postnatal bone development and bone remodeling remain unclear. Our data from fate mapping, scRNA-seq, and bone injury model suggest that progenies of Cx3cr1^+^ yolk-sac macrophage arise independently from the HSC lineage and can produce long-lasting osteoclast, whereas Csf1r^+^ precursors could not. One explanation for this finding is that a specific population of Cx3cr1^+^ cells at E9.5 provide the long-lasting osteoclasts. The other possibility may in part depend on the Cre recombination ability between *Csf1r-Mer-iCre-Mer* and *Cx3cr1*^*CreER*^ mice.

In bone development, osteoclast precursors migrate in the mesenchyme surrounding the bone rudiments. They differentiate into TRAP^+^ cells and change into mature osteoclasts to curve the bone matrix and generate space for hematopoiesis^[@R53]^. EMP-derived osteoclasts play a crucial role in the production of the bone cavity and accelerate the transfer of HSCs into the bone cavity. EMP-derived osteoclasts decreased by 0.5 months of age when this function is completed. An additional population of EMP-derived macrophages could survive in the body and continuously provide osteoclast precursors later than 0.5 months old, representing long-lasting osteoclasts in adult mice.

We found the spleen can be a source of EMP-derived osteoclast precursors. However, the nature of their establishment in the spleen and the biological mechanisms of response to the bone injury are still unclear. Nakamichi et al. found that IL-34 signaling induced mobilization of osteoclast precursors from the spleen in osteopetrotic *op/op* mice^[@R50]^. Further, Sabatel et al. reported that lung interstitial macrophages arise from splenic reservoir monocytes through IL-10 signaling during allergic airway inflammation^[@R54]^. Clarification of the detailed network orchestrating the recruitment of EMP-derived osteoclasts is required.

In summary, we found that osteoclasts derive from EMPs and are involved in bone remodeling. Our recent findings provide a framework of osteoclast ontogeny and diversity of those precursor cells. Future study of the differences between osteoclasts from these populations will inform the optimal method to modulate osteoclast functions and increase the evidence that enhance our understanding that EMP-derived osteoclasts are a unique precursor population with a specific role in bone homeostasis.

Methods {#S10}
=======

Mouse strains {#S11}
-------------

All animals were used according to the approved protocol by the Institutional Animal Care and Use Committee of Duke University. *Csf1r-Mer-iCre-Mer* (*FVB-Tg(Csf1r-cre/Esr1\*)1Jwp/J*), *Cx3cr1*^*CreER　*^(*B6.129P2(C)-Cx3cr1*^*tm2.1(cre/ERT2)Jung*^*/J*), *R26*^*tdTomato*^ (*B6.Cg-Gt(ROSA)26Sor*^*tm14(CAG-tdTomato)Hze*^*/J*), *Csf1r-EGFP* (*C57BL/6-Tg(Csf1r-EGFP-NGFR/FKBP1A/TNFRSF6)2Bck/J*), *Cx3cr1*^*EGFP*^ (*B6.129P-Cx3cr1*^*tm1Litt*^*/J*), and *C57BL/6J* mice were purchased from Jackson Laboratory. *Flt3-Cre* mice have been previously described^[@R55]^ and kindly provided by Dr. K. Lavine (Washington University). All mice were bred under specific-pathogen-free conditions. *Csf1r-Mer-iCre-Mer*, *Cx3cr1*^*CreER*^, and *Flt3-Cre* mice were mated with *R26*^*tdTomato*^ mice to generate either *Csf1r-Mer-iCre-Mer; R26*^*tdTomato*^, *Cx3cr1*^*CreER*^; *R26*^*tdTomato*^, or *Flt3-Cre; R26*^*tdTomato*^ mice. In some experiments, *Csf1r-Mer-iCre-Mer; R26*^*tdTomato*^ and *Csf1r-EGFP* mice were crossed to obtain *Csf1r-Mer-iCre-Mer; Csf1r-EGFP; R26*^*tdTomato*^ mice. *Csf1r-Mer-iCre-Mer* mice were maintained in a mixed background of *FVB* and *C57BL/6J*. Genotyping PCR of each strain was performed according to the instructions provided by Jackson Laboratory. Embryonic development was defined based on the date of vaginal plug formation as embryonic day 0.5. To achieve Cre-recombination, 75 μg per g (bodyweight) of 4-hydroxytamoxifen (4OHT, Sigma Aldrich) dissolved in corn oil (Sigma Aldrich) was intraperitoneally injected into a pregnant female. 4OHT was supplemented with 37.5 μg per g (bodyweight) progesterone (Sigma Aldrich) to avoid fetal abortions.

Histological analysis {#S12}
---------------------

Samples were fixed in 4% paraformaldehyde (PFA)/phosphate-buffered saline (PBS) at 4 °C, followed by incubation in 30% sucrose in PBS (Sigma Aldrich) for overnight. Tissues were embedded in Tissue-tek O.C.T. compound (Sakura Finetek). Sections were prepared at 10 μm thickness with a Cryofilm type 3c(16UF) (SECTION-LAB) using a CM1950 cryomicrotome (Leica) according to the method described by Kawamoto^[@R56]^. Sections were stained with Hoechst 33342 (1:2000, Thermo Fisher Scientific) to visualize the nuclei. tdTomato and EGFP fluorescence were captured using Axio Imager Widefield Fluorescence Microscope (Zeiss) or BZ-9000 Biorevo microscope (Keyence). For immunostaining of F4/80, Vpp3, and Ki67, sections were blocked with 10% normal goat serum (VECTOR LABORATORIES) in PBS for 1 hour at room temperature. Then sections were incubated with rat anti-mouse F4/80 (1:200, Biorad), rabbit anti-ATP6V1B1 + ATP6V1B2 (1:200, Abcam), or rat anti-Ki67 (1:200, Thermo Fisher Scientific) antibody for overnight at 4 °C. Anti-rat Alexa Fluor 647 (1:2000, Thermo Fisher Scientific) and anti-rabbit Alexa Fluor 488 (1:2000, Thermo Fisher Scientific) were used as the secondary antibody. After nuclei staining with Hoechst 33342, sections were visualized using Axio Imager Widefield Fluorescence Microscope (Zeiss) or IX-83 (OLYMPUS).

For paraffin-embedded sections, samples were harvested, fixed in 4% PFA, processed, and embedded in paraffin. Sections were prepared at 5 μm thickness and subjected to hematoxylin and eosin staining after deparaffinization. To detect tdTomato expression, sections were incubated in citric acid-based antigen unmasking solution (VECTOR LABORATORIES) at 80°C for 15 minutes (min) to retrieve the antigen. Endogenous peroxidase was blocked by 3% H~2~O~2~/Methanol for 10 min. After blocking with 10% goat normal serum (VECTOR LABORATORIES), the sections were incubated with a rabbit anti-RFP antibody (1:500, Rockland) for 2 hours at room temperature. Immunodetection was performed using VECTASTAIN ABC rabbit IgG Kit and ImmPACT DAB peroxidase (HRP) Substrate (VECTOR LABORATORIES). Sections were then counterstained with hematoxylin and mounted.

Tartrate-resistant acid phosphatase (TRAP) staining {#S13}
---------------------------------------------------

To visualize tdTomato^+^ and TRAP^+^ cells, frozen sections, described above as Kawamoto film methods, were used. First, tdTomato expression was captured by Axio Imager Widefield Fluorescence Microscope (Zeiss) without embedding. Then, sections were subjected to TRAP staining. TRAP staining solution containing Naphthol AS-MX phosphate (Sigma) and Fast Red Violet LB salt (Sigma), diluted in L-(+) Tartaric Acid (Sigma) incubation medium, were placed on the film and incubated at 37°C for 15 min. After washing the film, sections were embedded with SCMM-G1 (SECTION-LAB) and captured by Axio Imager Widefield Fluorescence Microscope (Zeiss). To merge the two types of images, Photoshop (Adobe) was used. Quantitative histological evaluations were then performed.

Preparation of cell suspensions, flow cytometry, and cell sorting {#S14}
-----------------------------------------------------------------

To obtain single-cell suspension from E14.5 embryos, pregnant females were euthanized by exposure to CO~2~. Embryos were collected from the uterus and washed with PBS. Each embryo was minced by a scalpel, and then digested with 1 mg ml^−1^ collagenase D (Roche), 100 U ml^−1^ DNase I (Sigma Aldrich) in 1% Bovine serum albumin (BSA, Sigma)/PBS for 20 min at 37 °C. The whole-body cell suspension was filtered by 70- and 30-μm cell strainer. To obtain the bone marrow cells (BMCs), 2-month-old mice tibia were used. Bilateral tibia were dissected, and the distal/proximal end of the tibia were removed. BMCs were then collected and mechanically dissociated to make a single cell suspension. BMCs were then filtered by 40-μm cell strainer.

Cell suspensions were centrifuged at 1200 rpm for 5 min and then treated with ACK lysis buffer (Thermo Fisher Scientific) for 3 min. After 5 min incubation with purified rat anti-mouse CD16/32 (mouse BD Fc block, BD Biosciences), antibody mixes were added and incubated for 30 min at 4 °C. All antibodies are listed in [Supplementary Table 3](#SD2){ref-type="supplementary-material"}. Flow cytometry was performed with a FACSCanto II flow cytometer (BD Biosciences). Data were analyzed by FlowJo 10 (Tree Star). For cell sorting, a DiVa cell sorter (BD Biosciences) was used, and the sorted cells were subjected to either scRNA-seq or primary osteoclast cultures.

scRNA library preparation and sequencing {#S15}
----------------------------------------

Cell suspensions were loaded on the 10x Genomics Chromium Controller Single-Cell Instrument (10x Genomics) mixed with reverse transcription reagents along with gel beads and oil to generate single-cell gel bead in emulsions (GEMs). GEM-RT was performed in an Eppendorf Mastercycler Pro (Eppendorf): 53 °C for 45 min, 85 °C for 5 min; held at 4 °C. After RT, GEMs were broken and the single-strand cDNA was purified with DynaBeads MyOne Silane Beads (Thermo Fisher Scientific). cDNA was amplified using the Eppendorf Mastercycler Pro (Eppendorf): 98°C for 3 min; cycled 11--13×: 98 °C for 15s, 67 °C for 20 s, and 72 °C for 1 min; 72 °C for1 min; held at 4 °C. Amplified cDNA product was purified with the SPRIselect Reagent Kit (0.6 × SPRI) (Beckman Coulter). Indexed sequencing libraries were constructed using the reagents in the Chromium Single-Cell 3′ Library Kit, following these steps: (1) fragmentation, end repair and A-tailing; (2) SPRIselect cleanup; (3) adapter ligation; (4) post ligation cleanup with SPRIselect; (5) sample index PCR; (6) PostindexPCR cleanup. The barcoded sequencing libraries were quantified by quantitative PCR (KAPA Biosystems Library Quantification Kit for Illumina platforms). Sequencing libraries were transferred to the Duke University Center for Genomic and Computational Biology (GCB) and were loaded on a Novaseq 6000 (Illumina) for sequencing.

The primary analytical pipeline for the single cell analysis followed the recommended protocols from 10X Genomics. Briefly, we processed the raw FASTQ files using the most current version of the Cell Ranger software. The first steps of this program demultiplex the raw reads and align the reads to the appropriate reference transcriptome and gene expression matrices created for all single cells in each sample (<http://support.10xgenomics.com/single-cell/software/pipelines/latest/what-is-cell-ranger>). The secondary statistical analysis was performed using R statistical methodology, R package Seurat (<http://satijalab.org/seurat/>), which performs quality control and subsequent analyses on the gene expression matrices produced by CellRanger. In Seurat data was first normalized on the log scale after basic filtering for minimum gene and cell observance frequency cut-offs (<http://satijalab.org/seurat/pbmc3k_tutorial.html>). We then closely examined the data and performed further filtering based on a range of metrics in an attempt to identify and exclude possible multiplets. The additional removal of further technical artifacts, in order to reduce noise, was performed using regression methods. After quality control procedures were complete, we calculated principal components using the most variably expressed genes in our dataset. Significant principal components for downstream analyses were determined through methods mirroring those implemented by Macosko et al.^[@R57]^, and these principal components were carried forward for two main purposes: to perform cell clustering and to enhance visualization. Cells were grouped into an optimal number of clusters for de novo cell type discovery using Seurat's FindClusters function, graph-based clustering approach with visualization of cells through the use of t-distributed stochastic neighbor embedding (t-SNE), which reduced the information captured in the selected significant principal components to two dimensions^[@R58]^. Differential expression of relevant cell marker genes was visualized on the t-SNE plot to reveal specific individual cell types.

Quantitative PCR {#S16}
----------------

Total RNA was extracted from whole embryos at E8.5 and bone marrow cells at 2-month-old using Trizol reagent (ambient) and Direct-zol RNA Microprep (Genesee Scientific). cDNA was then reverse-transcribed by using Maxima H Minus cDNA Synthesis Master Mix (Invitrogen, M1662). Real-time PCR was then performed with the following primers using the Powerup SYBR green reagent (Invitrogen, A25777) on a QuantStudio 3 real-time PCR system (Thermo Fisher Scientific). Gene expression was calculated and expressed relative to a housekeeping gene (Hprt) using the ΔΔCT-method. Cre-forward primer; ACGTTCACCGGCATCAACGT, Cre-reverse; CTGCATTACCGGTCGATGCA, Hprt-forward; GGCTATAAGTTCTTTGCTGACCTG, and Hprt-reverse; AACTTTTATGTCCCCCGTTGA.

Pathway analysis {#S17}
----------------

Pathway analysis was performed using ToppGene Suite (<https://toppgene.cchmc.org/help/publications.jsp>). We used a total of 163 differentially expressed genes in cluster 6 of tdTomato^+^Tnfrsf11a^+^Ptprc^+^ cells to identify the significantly upregulated pathways based on functional annotations and protein interactions network.

In vitro Osteoclast differentiation {#S18}
-----------------------------------

tdTomato^+^ cells were isolated from whole-body cell suspension of E14.5 *Csf1r-Mer-iCre-Mer; R26*^*tdTomato*^ and *Cx3cr1*^*CreER*^*; R26*^*tdTomato*^ embryo and tdTomato^+^ cells were seeded in a 48-well plate (20,000 cells per well). Cells were cultured in α-MEM (Thermo Fisher Scientific) with 20% FBS (Sigma) containing 50 ng/ml M-CSF (R&D Systems) for two days. Cells were then cultured in the presence of 50 ng/ml soluble RANKL (Peprotech) and 50 ng/ml M-CSF for three days.

BMSc from *Flt3-Cre; R26*^*tdTomato*^ and *C57BL/6J* mice were isolated and seeded in 10 cm dish. Nonadherent bone marrow cells were seeded (20, 000 cells per well of 48-well plate) and cultured in α-MEM with 20% FBS containing 50 ng/ml M-CSF for two days. Cells were then cultured in the presence of 50 ng/ml soluble RANKL and 50 ng/ml M-CSF for three days.

Cells were fixed with 4% PFA/PBS and subjected to TRAP staining. Multinucleated (\>3 nuclei) TRAP^+^ cells were counted as osteoclast and captured by BZ-9000 Biorevo microscope (Keyence).

Drill hole surgery {#S19}
------------------

Two-month-old mice received the drill hole surgery under the anesthesia. A 22G needle (0.7 mm diameter, BD) was used to create a hole on the right femur approximately 6 mm above the knee joint without a skin incision. Mice were sacrificed at 3, 7, 14, and 21 days after surgery and subjected to μCT (VivaCT 80, Scanco Medical) and histological analysis.

Parabiosis surgery {#S20}
------------------

Two mice were habituated in the same cage to ensure harmonious cohabitation. After the anesthesia, a longitudinal skin incision was performed from elbow to knee joint. After a suturing at the olecranon, muscle and subcutaneous tissue of the two mice were connected by continuous sutures. A skin suture was then performed in the area from the elbow to knee joint. Mice were monitored daily to observe for signs of pain and distress such as shaking, lethargy, chewing of the tail, arched back, and lack of grooming. After a total three weeks combination, a mouse received a drill hole surgery on the right femur under the anesthesia. Two weeks after the drill hole surgery, mice were sacrificed and subjected to histological analysis.

Splenectomy surgery {#S21}
-------------------

After the anesthesia, the abdominal cavity was exposed through a left lateral incision extending around 1cm. Splenic vessels were collapsed with cautery, then the spleen was removed with the scissors. The abdominal musculature and the skin were closed with suture.

Statistical analysis and reproducibility {#S22}
----------------------------------------

Data are shown as averages and standard deviations with individual values per sample. Statistical analysis was performed with either Prism (GraphPad) or Statcel3 (OMS) using unpaired two-tailed t-test and ANOVA followed by the Tukey-Kramer post-hoc test. Significance was considered at P\<0.05. All statistical analysis performed in this manuscript and their respective parameters are shown in the Figure legends and Statistical source data [Fig. 1](#F1){ref-type="fig"}--[6](#F6){ref-type="fig"} and Statistical source data [Extended data Fig. 3](#F9){ref-type="fig"}, [5](#F11){ref-type="fig"}, [6](#F12){ref-type="fig"}, and [7](#F13){ref-type="fig"}.

The number (n) of biological pepeats has been indicated in each figure legend. All representative data are shown from independently repeated experiments or independents animals with similar results.

Data availability {#S23}
-----------------

Single cell RNA sequencing data that support the findings of this study have been deposited in the Gene Expression Omnibus (GEO) under accession code GSE125088. Source data have been provided as Statistical source data [Fig. 1](#F1){ref-type="fig"}--[6](#F6){ref-type="fig"} and Statistical source data [Extended data Fig. 3](#F9){ref-type="fig"}, [5](#F11){ref-type="fig"}, [6](#F12){ref-type="fig"}, and [7](#F13){ref-type="fig"}. All other data supporting the findings of this study are available from the corresponding author on reasonable request.

Extended Data {#S39}
=============

![Non-leakiness of *Csf1r-Mer-iCre-Mer* mice. (a) Representative image of the postnatal day (P) 0 femur of *Csf1r-Mer-iCre-Mer*; *R26^tdTomato^* mice without 4 hydroxytamoxifen (4OHT) induction (n=3 mice). Scale bars, upper panel; 500 μm. Lower panels; 100 μm.](nihms-1543828-f0007){#F7}

![Cx3cr1+ yolk-sac macrophage descendant in several skeletal elements. (a) Representative image of the postnatal day (P) 3 femur of *Cx3cr1^CreER^*; *R26^tdTomato^* mice without 4 hydroxytamoxifen (4OHT) induction (n=3 mice). Scale bar, 100 μm. (b) Representative images of tdTomato+ cells in neonatal brain and calvaria of *Cx3cr1^CreER^*; *R26^tdTomato^* mice treated with 4OHT at E9.5 (n=3 mice). Scale bars, 50 μm. (c) Representative image of tdTomato and F4/80 expression in the scapula of 2-month-old (mo) *Cx3cr1^CreER^*; *R26^tdTomato^* mice labeled at E9.5 (n=3 mice). Scale bar, 50 μm. (d) Representative image of tdTomato and F4/80 expression in the vertebral body of 2 mo *Cx3cr1^CreER^*; *R26^tdTomato^* mice labeled at E9.5 (n=3 mice). Scale bars, 50 μm.](nihms-1543828-f0008){#F8}

![Characterization of HSC- and EMP- derived cells. (a) Representative image of the femur of embryonic day (E) 17.5 *R26^tdTomato^* mice (Cre-negative littermate control of *Flt3-Cre*; *R26^tdTomato^* mice, n = 3 mice). Scale bar, 100 μm. (b) Relative mRNA expression levels of Cre were analyzed by quantitative PCR. RNA was isolated from adult bone marrow cells (BMCs) and E8.5 whole body. *Flt3-Cre*; *R26^tdTomato^* mice and their littermate Cre-negative control were used. (c) Gating strategy of CD45+tdTomato+ BMCs. (d) Flow cytometry analysis of tdTomato+ cells from whole-body cell suspension of E14.5 *Csf1r-Mer-iCre-Mer*; *R26^tdTomato^* mice labeled at E8.5 (n = 6 embryos) and *Cx3cr1^CreER^*; *R26^tdTomato^* mice labeled at E9.5 (n = 5 embryos). 4OHT, 4-hydroxytamoxifen. (e) Quantitative visualization of percentage of tdTomato+ and RANK+ cells from whole-body cell suspension of E14.5 *Csf1r-Mer-iCre-Mer*; *R26^tdTomato^* mice labeled at E8.5 (n = 6 embryos) and *Cx3cr1^CreER^*; *R26^tdTomato^* mice labeled at E9.5 (n = 5 embryos). Unpaired two-tailed t-test. Error bars denote means ± s.d. (f) Percentage of F4/80^high^CD11b^int^ macrophage and CD11b^high^F4/80^int^ monocyte isolated from E14.5 whole body lysate of *Csf1r-Mer-iCre-Mer*; *R26^tdTomato^* mice labeled at E8.5 (n = 6 embryos) and *Cx3cr1^CreER^*; *R26^tdTomato^* mice labeled at E9.5 (n = 5 embryos). Statistics source data are provided in Source Data Extended Data Fig. 3.](nihms-1543828-f0009){#F9}

![Single cell RNA-sequencing analysis of E14.5 embryo. (a) Schematic representation of sample preparation for the single cell RNA-sequencing. 4OHT, 4-hydroxytamoxifen. (b) Cell sorting strategy for the single cell RNA-sequencing. tdTomato+EGFP-, tdTomato+EGFP+, and tdTomato-EGFP+ (red box) were isolated from whole-body cell suspension of *Csf1r-Mer-iCre-Mer*; *Csf1r-EGFP*; *R26^tdTomato^* mice labeled at E8.5. tdTomato+CX3CR1-, tdTomato+CX3CR1+, and tdTomato-CX3CR1+ cell populations (green box) were also isolated from E14.5 *Cx3cr1^CreER^*; *R26^tdTomato^* mice labeled at E9.5. Two biological replicates of each genotype. (c) Dot plot showing expression of the selected marker gene in each cluster of *Csf1r-Mer-iCre-Mer*; *Csf1r-EGFP*; *R26^tdTomato^* mice. The size of the dot encodes the percentage expression, and its color encodes the average expression level. (d) Dot plot showing expression of the selected marker gene in each cluster of *Cx3cr1^CreER^*; *R26^tdTomato^* mice. (e) Scaled expression level and frequency (the number of cells) of *tdTomato*, *Myb*, and *Flt3* were visualized. tdTomato+ cells from *Csf1r-Mer-iCre-Mer*; *Csf1r-EGFP*; *R26^tdTomato^* (n=10,336 cells) and *Cx3cr1^CreER^*; *R26^tdTomato^* (n=6,706 cells) mice were evaluated.](nihms-1543828-f0010){#F10}

![Single cell RNA sequencing identified EMP-derived osteoclast and their precursor populations. (a) t-SNE plot of tdTomato+Tnfrsf11a+Ptprc+ cells (n=3,368 cells) from *Csf1r-Mer-iCre-Mer*; *Csf1r-EGFP*; *R26^tdTomato^* and *Cx3cr1^CreER^*; *R26^tdTomato^* mice identifying 13 clusters. The right gray rectangle representing the normalized expression of indicated marker genes visualized onto t-SNE plots. Cells in cluster 9 expressed osteoclast-specific marker genes. EMP, erythromyeloid progenitor. (b) Heatmap representing the top 10 significantly differentially expressed genes in each cluster. (c) Violin plots showing mRNA expression levels of selected marker genes. Green color showing the expression levels of the cells from *Cx3cr1^CreER^*; *R26^tdTomato^* mice. Blue color showing the expression levels of the cells from *Csf1r-Mer-iCre-Mer*; *Csf1r-EGFP*; *R26^tdTomato^* mice. The number shows cluster identity, and the number of cells in each cluster is provided in Statistical source data Extended Data Fig 5. (d) Selected pathways significantly enriched in the cells belonging cluster 6 (n=274 cells). Hypergeometric probability mass function was used. Statistics source data are provided in Source Data Extended Data Fig. 5.](nihms-1543828-f0011){#F11}

![The healing process of the bone injury. (a) Representative images of the bone injury site during the healing process. 2-month-old *C57BL/6J* mice received drill hole injury and were analyzed (n=3 mice per group). Hematoxylin and Eosin staining showing inflammatory cells (day 3), newly synthesized bone (day 7), and regenerated bone tissue (day 21). Scale bars, 100 μm. (b) Immunohistochemical analysis for F4/80 expression. Representative images showing F4/80+ macrophages around the injury site at day 3 (n=3 mice). Scale bars, 100 μm. (c) Representative images of tdTomato+ cells around the injury site. 2-month-old *Csf1r-Mer-iCre-Mer*; *R26^tdTomato^* mice induced with 4OHT at E9.5 received drill hole injury and were analyzed at day 3 (n=3), 7 (n=3), 14 (n=4), and 21 (n=5). n representing independent animals. White dot lines represent the injury site. 4OHT, 4-hydroxytamoxifen. Scale bars, 100 μm. (d) Representative visualization of tdTomato+ and TRAP+ cells showing less contribution of tdTomato+ cells to the bone remodeling at day 14 (n=4 mice). Scale bars, 50 μm. (e) Percentage of tdTomato+TRAP+ to TRAP+ cells around the injury site of *Csf1r-Mer-iCre-Mer*; *R26^tdTomato^* mice at day 3 (n=3), 7 (n=3), 14 (n=4), and 21 (n=5). n representing independent animals. Statistics source data are provided in Source Data Extended Data Fig. 6.](nihms-1543828-f0012){#F12}

![Migration of EMP-derived osteoclast precursors through the blood circulation. (a) Immunohistochemical analysis for Ki67 expression. Representative images showing Ki67+ and tdTomato+ cells around the injury site and adjacent metaphysis at day 14 (n=3 mice per group). Scale bars, 50 μm. (b) The number of single positive cells of Ki67 and tdTomato and double-positive cells per 0.3 mm2 were quantified (n=3 mice per group). Error bars denote means ± s.d. (c) Representative images of the injured femur of *Cx3cr1^EGFP/+^* mice after the parabiotic union. tdTomato+ cells migrated through the blood circulation at the site of a bone injury. Scale bars, 1 mm. Right panels showing enlarged images (n=4 independent parabiotic pairs). Scale bars, 100 μm. (d) Representative images of uninjured side femur of *Cx3cr1^EGFP/+^* mice. Scale bars, 1 mm. Right panels showing enlarged images (n = 4 independent parabiotic pairs). White triangles indicating tdTomato+ cells. Scale bars, 100 μm. (e) The number of tdTomato+ cells around the injury site and contralateral side of the femur. tdTomato+ cells per 1.26 mm2 were counted and visualized by bar chart (n = 4 mice per group). Unpaired two-tailed t-test. Error bars denote means ± s.d. Statistics source data are provided in Source Data Extended Data Fig. 7.](nihms-1543828-f0013){#F13}

![Schematic representation showing the differential origin of osteoclast precursors and their differentiation. Myb-independent early erythromyeloid progenitors (EMPs) appear around E7--7.5 in the yolk-sac and differentiate into Csf1r+ yolk-sac macrophage (YS Mac) at E8.5 without passing through monocyte intermediates. YS Mac differentiates into CX3C chemokine receptor 1 (CX3CR1) positive premacrophage (pMac), resulting in a significant source of yolk-sac-derived macrophages. Late EMPs emerge in the yolk-sac at E8.5 and migrate to the fetal liver to produce Myb-expressing fetal liver (FL) myeloid progenitors (MP), resulting in FL monocyte (FL Mono). Hematopoietic stem cell precursors (pro-HSCs) emerge at E10.5. Pro-HSCs migrate to the fetal liver around E12 and turns to fetal HSCs, which later shift to the bone marrow. Bone marrow HSCs eventually can establish the circulating monocyte-derived macrophages. YS-derived macrophages differentiate into osteoclast (YS-derived Oc) in the neonatal bone with possible cell-cell fusion with HSC-derived Oc precursors. Cx3cr1+ yolk-sac macrophage descendants in the spleen can provide long-lasting Oc that contribute to the postnatal bone remodeling after injury via the bloodstream.](nihms-1543828-f0014){#F14}

Supplementary Material {#SM1}
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###### 

List of differentially expressed genes in cluster 9 of tdTomato^+^Tnfrsf11a^+^Ptprc^+^ cells (total 94 cells) compared to all remaining cells. Non-parameteric Wilcoxon rank sum test was used.

List of differentially expressed genes in cluster 6 of tdTomato^+^Tnfrsf11a^+^Ptprc^+^ cells (total 274 cells) compared to all remaining cells. Non-parameteric Wilcoxon rank sum test was used.
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![Csf1r^+^ yolk-sac macrophages give rise to the neonatal osteoclasts.\
(a) Schematic representation of the fate-mapping analysis of *Csf1r*-expressing cells and their progenies. E, embryonic day. P, postnatal day. mo, month-old. 4OHT, 4-hydroxytamoxifen. (b) Representative images of tdTomato expressing cells on the postnatal femurs at defined ages and time point of 4OHT induction (P0 (E7.5, n=4; E8.5, n=5; E9.5, n=4), 0.5 mo (E8.5, n=5; E9.5, n=5), 2 mo (E8.5, n=4; E9.5, n=5), and 6 mo (E9.5, n=4)). n representing independent animals. mp, metaphysis. dp, diaphysis. Scale bars, 50 μm. (c) The number of tdTomato^+^ cells in the metaphysis per 0.32 mm^2^ at P0 (E7.5, n=4; E8.5, n=5; E9.5, n=4), 0.5 mo (E7.5, n=5; E8.5, n=5; E9.5, n=5), and 2 mo (E8.5, n=4; E9.5, n=5). n representing independent animals. One-way ANOVA (P0, 0.5 mo) and unpaired two-tailed t-test (2 mo). Error bars denote means ± s.d. (d) Percentage of tdTomato^+^ surface area to the total bone surface area of the endosteum at 0.5 mo (E7.5, n=5; E8.5, n=5; E9.5, n=5) and 2 mo (E8.5, n=4; E9.5, n=5). n representing independent animals. One-way ANOVA (0.5 mo) and unpaired two-tailed t-test (2 mo). Error bars denote means ± s.d. (e) Representative image of immunostaining for tdTomato indicating the multinucleation of tdTomato^+^ cells from three independent experiments. Scale bar, 50 μm. (f) Representative image of tdTomato expression and antibody staining with Vpp3. Nuclei staining with hoechst showing the multinucleation. Three independent experiments. Scale bar, 50 μm. (g) Representative image of tdTomato^+^ and TRAP^+^ cells on the postnatal femur at defined age and time point of 4OHT induction (P0 (E7.5, n=4; E8.5, n=5; E9.5, n=4), 0.5 mo (E8.5, n=5; E9.5, n=5), 2 mo (E9.5, n=5)). n representing independent animals. Scale bars, 50 μm. (h) Percentage of tdTomato^+^TRAP^+^ cells to total TRAP^+^ cells in the metaphysis (P0 (E8.5, n=5; E9.5, n=4), 0.5 mo (E8.5, n=5; E9.5, n=5), 2 mo (E8.5, n=4, E9.5, n=5), 6 mo (E9.5, n=4)). n representing independent animals. Error bars denote means ± s.d. Statistics source data are provided in Source Data [Fig. 1](#F1){ref-type="fig"}.](nihms-1543828-f0001){#F1}

![Cx3cr1^+^ yolk-sac macrophages give rise to the osteoclasts that survive in adulthood.\
(a) Schematic representation of the fate-mapping analysis of *Cx3cr1*-expressing cells and their progenies. E, embryonic day. P, postnatal day. mo, month-old. 4OHT, 4-hydroxytamoxifen. (b) Representative images of tdTomato expressing cells on the postnatal femur at P0 (E8.5, n=5; E9.5, n=5), 0.5 mo (E8.5, n=4; E9.5, n=5), 2 mo (E8.5, n=3; E9.5, n=5), and 6 mo (E9.5, n=4). n representing independent animals. mp, metaphysis. dp, diaphysis. Scale bars, 50 μm. (c) The number of tdTomato^+^ cells in the metaphysis per 0.32 mm^2^ at P0 (E8.5, n=5; E9.5, n=5), 0.5 mo (E8.5, n=4; E9.5, n=5), and 2 mo (E8.5, n=3; E9.5, n=5). n representing independent animals. Unpaired two-tailed t-test. Error bars denote means ± s.d. (d) Percentage of tdTomato^+^ surface area to the total bone surface area of the endosteum at 0.5 mo (E8.5, n=4; E9.5, n=5) and 2 mo (E8.5, n=3; E9.5, n=5). n representing independent animals. Unpaired two-tailed t-test. Error bars denote means ± s.d. (e) Representative image of immunostaining for tdTomato indicating the multinucleation of tdTomato^+^ cells from three independent experiments. Scale bar, 50 μm. (f) Representative images of tdTomato^+^ and TRAP^+^ cells on the postnatal femur at defined age and time point of 4OHT induction (E8.5; P0, n=5. E9.5; P0, n=5; 0.5 mo, n=5; 2 mo, n=5; 6 mo, n=4). n representing independent animals. Scale bars, 50 μm. (g) Percentage of tdTomato^+^TRAP^+^ cells to total TRAP^+^ cells in the metaphysis (E8.5; P0, n=5; 0.5 mo, n=4; 2 mo, n=3. E9.5; P0, n=5; 0.5 mo, n=5; 2 mo, n=5; 6 mo, n=4). n representing independent animals. Error bars denote means ± s.d. Statistics source data are provided in Source Data [Fig. 2](#F2){ref-type="fig"}.](nihms-1543828-f0002){#F2}

![EMPs and HSCs give rise to the postnatal osteoclast.\
(a) Representative images of tdTomato expressing cells on the femur of *Flt3-Cre; R26*^*tdTomato*^ mice at defined age (n=3 mice per group). E, embryonic day. P, postnatal day, mo, month-old. mp, metaphysis. dp, diaphysis. Scale bars, 50 μm. (b) Representative images of tdTomato^+^ and TRAP^+^ cells of 2 mo *Flt3-Cre; R26*^*tdTomato*^ mice femur (n=3 mice). Scale bars, 50 μm. (c) Representative image of tdTomato expression and antibody staining with Vpp3. Nuclei staining with hoechst showing the multinucleation. Three independent experiments. Scale bar, 50 μm. (d) Quantification of the percentage of tdTomato^+^TRAP^+^ cells to total TRAP^+^ cells in the metaphysis of *Flt3-Cre; R26*^*tdTomato*^ mice at E17.5 (n=4 mice), P0 (n=3 mice), and 2 mo (n=5 mice) of age. E17.5 *R26*^*tdTomato*^ mice (n=3 mice) were used as Cre negative control. One-way ANOVA was used to compare among E17.5, P0, and 2 mo *Flt3-Cre; R26*^*tdTomato*^ mice. Error bars denote means ± s.d. (e) Flow cytometry analysis of bone marrow cell (BMC) from 2 mo *Csf1r-Mer-iCre-Mer; R26*^*tdTomato*^ and *Cx3cr1*^*CreER*^*; R26*^*tdTomato*^ mice treated with 4OHT at E8.5 or E9.5 and *Flt3-Cre; R26*^*tdTomato*^ mice (n=4 mice per group). (f) Quantification of percentage of tdTomato^+^ cells per CD45^+^ BMCs of 2 mo *Csf1r-Mer-iCre-Mer; R26*^*tdTomato*^, *Cx3cr1*^*CreER*^*; R26*^*tdTomato*^, and *Flt3-Cre; R26*^*tdTomato*^ mice (n=4 mice per group). One-way ANOVA. Error bars denote means ± s.d. (g) *In vitro* osteoclast differentiation of tdTomato^+^ cells from E14.5 *Csf1r-Mer-iCre-Mer; R26*^*tdTomato*^ mice labeled at E8.5 and *Cx3cr1*^*CreER*^*; R26*^*tdTomato*^ mice labeled at E9.5 (representative image from three independent experiments). BMCs were isolated from 2 mo *Flt3-Cre; R26*^*tdTomato*^ mice and *C57BL6/J* mice (representative image from two independent experiments) and differentiated into osteoclast. Upper panels showing TRAP staining and lower panels showing tdTomato expression. Scale bars, 100 μm. (h) The number of multinucleated TRAP^+^ cells per 4.8 mm^2^. Data were combined from two independent experiments (*Csf1r-Mer-iCre-Mer; R26*^*tdTomato*^, n=4 mice; *Cx3cr1*^*CreER*^*; R26*^*tdTomato*^, n=5 mice; *Flt3-Cre; R26*^*tdTomato*^, n=3 mice). TRAP-positive multinucleated cells with more than three nuclei were counted as osteoclasts. Error bars denote means ± s.d. Statistics source data are provided in Source Data [Fig. 3](#F3){ref-type="fig"}.](nihms-1543828-f0003){#F3}

![EMP- and HSC-derived cells specify distinct subpopulations.\
(a) t-distributed stochastic neighbor embedding (t-SNE) plot of 19,598 cells from *Csf1r-Mer-iCre-Mer; Csf1r-EGFP; R26*^*tdTomato*^ mice (n=2 mice) identified 29 clusters. (b) Violin plots showing *Csf1r* and *tdTomato* expression levels of the cells from *Csf1r-Mer-iCre-Mer; Csf1r-EGFP; R26*^*tdTomato*^ mice (n=2 mice). The number in the middle column show cluster identity and the number of cells in each cluster is provided in Statistical source data [Fig. 4](#F4){ref-type="fig"}. (c) Normalized expression of indicated marker genes was visualized onto t-SNE plots of 19,598 cells from *Csf1r-Mer-iCre-Mer; Csf1r-EGFP; R26*^*tdTomato*^ mice (n=2 mice). (d) Heatmap representing the top 10 significantly differentially expressed genes in each cluster. (e) The number of tdTomato^+^ cells in each cluster are shown with the expression level of *Flt3*. The number in the middle column show cluster identity and the number of cells and tdTomato^+^ cells in each cluster are provided in Statistical source data [Fig. 4](#F4){ref-type="fig"}. (f) t-SNE plot of 16,169 cells from *Cx3cr1*^*CreER*^*; R26*^*tdTomato*^ mice (n=2 mice) provided 21 clusters. (g) Violin plots showing *Cx3cr1* and *tdTomato* expression levels of the cells from *Cx3cr1*^*CreER*^*; R26*^*tdTomato*^ mice (n=2 mice). The number in the middle column show cluster identity and the number of cells in each cluster is provided in Statistical source data [Fig. 4](#F4){ref-type="fig"}. (h) Normalized expression of indicated marker genes was visualized onto t-SNE plots of 16,169 cells from *Cx3cr1*^*CreER*^*; R26*^*tdTomato*^ mice (n=2 mice). (i) Heatmap representing the top 10 significantly differentially expressed genes in each cluster. (j) The number of tdTomato^+^ cells in each cluster are shown with the expression level of *Flt3*. The number in the middle column show cluster identity and the number of cells and tdTomato^+^ cells in each cluster are provided in Statistical source data [Fig. 4](#F4){ref-type="fig"}. Statistics source data are provided in Source Data [Fig. 4](#F4){ref-type="fig"}.](nihms-1543828-f0004){#F4}

![Cx3cr1^+^ yolk-sac macrophage descendants provide osteoclasts after bone injury.\
(a) Schematic representation of the experimental procedure. 4OHT, 4-hydroxytamoxifen. (b) μCT of the injury site during bone healing (n=3 mice per group). Scale bars, 0.2 mm. (c) TRAP staining around the injury site at day 3 (n=8), 7 (n=7), 14 (n=11), and 21 (n=8). n representing independent animals. Black dot lines represent the site of the bone injury. Scale bars, 100 μm. (d) Number of TRAP^+^ cells around the injury site per 1.26 mm^2^ at day 3 (n=8), 7 (n=7), 14 (n=11), and 21 (n=8). n representing independent animals. One-way ANOVA. Error bars denote means ± s.d. (e) tdTomato^+^ cells around the injury site at day 3 (n=5), 7 (n=4), 14 (n=7), and 21 (n=5). n representing independent animals. White dot lines represent the injury site. Scale bars, 100 μm. (f) Number of tdTomato^+^TRAP^+^ cells and (g) Percentage of tdTomato^+^TRAP^+^ cells per TRAP^+^ cells around the injury site per 1.26 mm^2^ at day 3 (n=5), 7 (n=4), 14 (n=7), and 21 (n=5). n representing independent animals. One-way ANOVA. Error bars denote means ± s.d. (h) tdTomato^+^ and TRAP^+^ cells around the injury site at day 21 (n=5 mice). Scale bars, 100 μm. (i) Multinucleated tdTomato^+^ cells around the injury site at day 14 (n=3 mice). Scale bar, 10 μm. (j) F4/80 and tdTomato expression around the injury site at day 14 (n=3 mice). Scale bar, 50 μm. (k) tdTomato^+^ cells of 2-month-old *Flt3-Cre; R26*^*tdTomato*^ mice around the injury site. (n=3 mice per group). Lower panels showing magnified view. White dot lines represent the injury site. Scale bars, 100 μm. (l) TRAP staining, tdTomato expression and antibody staining with Vpp3 at day 14. Nuclei staining with hoechst showing the multinucleation (n=3 mice). Scale bar, upper; 100 μm. Lowers; 10 μm. (m) The number of tdTomato^+^TRAP^+^ cells and (n) percentage of tdTomato^+^TRAP^+^ cells per TRAP^+^ cells around the injury site per 1.26 mm^2^ (n=3 mice per group) of *Flt3-Cre; R26*^*tdTomato*^ mice. Unpaired two-tailed t-test. Error bars denote means ± s.d. Statistics source data are provided in Source Data [Fig. 5](#F5){ref-type="fig"}.](nihms-1543828-f0005){#F5}

![Cx3cr1^+^ yolk-sac macrophage descendants migrated into bone injury site through blood circulation.\
(a) Schematic representation of the experimental procedure. 4OHT, 4-hydroxytamoxifen. (b) Representative images of EGFP expression of the BMCs 5 weeks after parabiotic combination between *Cx3cr1*^*EGFP/+*^ and *Cx3cr1*^*CreER*^*; R26*^*tdTomato*^ mice induced with 4OHT at E9.5 (n= 3 mice per group). Scale bars, 50 μm. (c) The number of EGFP^+^ cells per 1.26 mm^2^ (n=3 mice per group). Unpaired two-tailed t-test. Error bars denote means ± s.d. (d) Representative images of tdTomato^+^ and EGFP^+^ cells around the injury site of *Cx3cr1*^*EGFP/+*^ mice 14 days after surgery. (n=4 independent parabiotic pairs). Left and middle panels showing tdTomato^+^ and EGFP^+^ cells. Right panel showing TRAP^+^ cells around the injury. Scale bars, 50 μm. (e) Representative images of tdTomato and EGFP expression around the injury site of *Cx3cr1*^*EGFP/+*^ mice at day 14 showing coexpression of tdTomato and EGFP. Nuclei staining with hoechst showing the multinucleation. Two of four independent parabiotic pairs showed coexpression of tdTomato and EGFP in injured *Cx3cr1*^*EGFP/+*^ mice. Scale bar, 50 μm. (f) Schematic representation of the experimental procedure. 4OHT, 4-hydroxytamoxifen. (g) Representative images of tdTomato expressing cells in the red pulp, marginal zone, and white pulp of the spleen of 2-month-old *Cx3cr1*^*CreER*^*; R26*^*tdTomato*^ mice labeled at E9.5 (n=3 mice per group). White dot lines representing the boundary between the red and white pulps. Scale bars, 50 μm. (h) The number of tdTomato^+^ cells in the red pulp, marginal zone, and white pulp of the spleen (n=3 per group). One-way ANOVA. Error bars denote means ± s.d. (i) Representative images of tdTomato^+^ cells around the injury site 14 days after injury with (n=5 mice) or without splenectomy (n=7 mice). Scale bars, 50 μm. (j) Quantitative analysis of tdTomato^+^ and TRAP^+^ cells around the injury site 14 days after injury with (n=5 mice) or without splenectomy (n =7 mice). Unpaired two-tailed t-test. Error bars denote means ± s.d. Statistics source data are provided in Source Data [Fig. 6](#F6){ref-type="fig"}.](nihms-1543828-f0006){#F6}
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